Skip to main content
ArticleOPEN ACCESS

Prevalence of SARS-CoV-2-specific antibodies, Japan, June 2020

Emerging Infectious Diseases
DOI: 10.3201/eid2702.204088
18Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

We used 2 commercially available antibody tests to estimate seroprevalence of severe acute respiratory syndrome coronavirus 2 infection in Japan during June 2020. Of 7,950 samples, 8 were positive by both assays. Using 2 reliable antibody tests in conjunction is an effective method for estimating seroprevalence in low prevalence settings.

Cite

CITATION STYLE

APA

Yoshiyama, T., Saito, Y., Masuda, K., Nakanishi, Y., Kido, Y., Uchimura, K., … Kato, K. (2021, February 1). Prevalence of SARS-CoV-2-specific antibodies, Japan, June 2020. Emerging Infectious Diseases. Centers for Disease Control and Prevention (CDC). https://doi.org/10.3201/eid2702.204088

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free